In a report released today, Laura Chico from Wedbush maintained a Buy rating on Neurocrine (NBIX – Research Report), with a price target of ...
Wedbush analyst David Nierengarten maintained a Buy rating on AnaptysBio (ANAB – Research Report) today and set a price target of $40.00. The ...
Seeking Alpha on MSN6h
Denny's rallies after Wedbush turns bullish on Keke's upside, earnings potentialDenny's (DENN) sees a rally after Wedbush upgrades stock on growth potential and expected earnings beat in Q4.
Hosted on MSN19h
Wedbush Initiates Coverage of Bicara Therapeutics (BCAX) with Outperform RecommendationFintel reports that on February 6, 2025, Wedbush initiated coverage of Bicara Therapeutics (NasdaqGM:BCAX) with a Outperform ...
Chipotle Mexican Grill (NYSE:CMG – Get Free Report) had its target price dropped by equities researchers at Wedbush from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback